MLO proteins are crucial for root hair growth by regulating calcium and ROS levels.
April 2025 in “International Journal of Medical Science and Diagnosis Research” The polyherbal shampoo effectively promotes hair growth and reduces dandruff.
April 2025 in “Archives of Dermatological Research” This study evaluated the efficacy and safety of a combination therapy of topical 0.1% finasteride and 5% minoxidil for male androgenetic alopecia over 12 weeks, involving 40 subjects. The combination therapy showed significant improvements in hair density, diameter, and terminal hair rate, similar to the control group using only 5% minoxidil, with no significant differences between the groups. Systemic side effects included libido reduction in the control group and mild erectile dysfunction and chest pain in the treatment group. Local side effects like itching, shedding, and dandruff were similar across groups, with one case of contact dermatitis in the treatment group. Overall, the combination therapy was as safe and effective as minoxidil alone in increasing hair density and diameter.
April 2025 in “The Journal of Clinical Endocrinology & Metabolism” Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.
April 2025 in “International Journal of Dermatology and Venereology” The study investigated the causal relationship between androgenetic alopecia (AGA) and schizophrenia using a bidirectional Mendelian randomization analysis. The forward MR analysis found a significant causal relationship between AGA and schizophrenia, with an odds ratio of 0.996 (95% CI: 0.992–0.999; P = 0.025). However, the reverse MR analysis showed no causal association between schizophrenia and AGA, with an odds ratio of 1.061 (95% CI: 0.965–1.165; P = 0.220). No heterogeneity or pleiotropy was observed in the analyses. Gene ontology and KEGG pathway analyses suggested that genes at SNP sites in the forward MR analysis were linked to various metabolic processes and signaling pathways. The study concludes that AGA may causally influence schizophrenia, but not vice versa.
April 2025 in “International Journal of Molecular Sciences” New treatments for hair loss show promise with advanced therapies and better targeting.
April 2025 in “The Journal of Urology” Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.
April 2025 in “Journal of Applied Cosmetology” The combined therapy of microneedling and light therapy effectively and safely promotes hair regrowth in trichotillomania.
April 2025 in “Acta Dermato Venereologica” Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.
April 2025 in “Journal of Cosmetic and Laser Therapy” The study compares the effectiveness of platelet-rich plasma (PRP) delivered via intradermal injection versus microneedle delivery for treating androgenetic alopecia. The research involved a sample size of 120 participants, divided into two groups, each receiving one of the treatment methods. Results indicated that both methods significantly improved hair density and thickness, but the microneedle delivery group showed slightly better outcomes in terms of patient satisfaction and hair regrowth. The study concludes that while both methods are effective, microneedle delivery may offer a marginal advantage in treating androgenetic alopecia.
April 2025 in “International Journal of Advanced Research in Science Communication and Technology” Herbal hair gummies with ingredients like fenugreek and biotin may help hair growth and are safe and stable.
April 2025 in “Pharmaceutics” Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.
April 2025 in “BMC Immunology” Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.
April 2025 in “Journal of Skin and Stem Cell” PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.
April 2025 in “International Journal of Cosmetic Science” A new hair perming method avoids damage and lasts longer than traditional methods.
Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.
April 2025 in “BioNanoScience” New methods using biomaterials, stem cells, and nanoparticles show promise for improving hair growth and treating hair loss.
April 2025 in “Pharmacognosy Magazine” Compound Baqia Danshen Liniment may effectively treat vitiligo by improving skin and hair pigmentation and reducing inflammation.
April 2025 in “Archives of Dermatological Research” This study on 156 patients with androgenetic alopecia compared treatment adherence between microneedling therapy (70 patients) and drug therapy (86 patients). The microneedling group showed higher adherence, influenced by factors like age, education, income, treatment duration, and side effects. Patients over 30, with higher education and income, and shorter treatment durations adhered better. Improved treatment efficacy and reduced anxiety were linked to better adherence. In the drug group, side effects and treatment efficacy were key, with severe conditions and depression increasing non-adherence. Microneedling reduced side effects and improved mental health, suggesting advantages in adherence. Future research should focus on the long-term efficacy and safety of microneedling.
April 2025 in “Research Square (Research Square)” Hemp seed exosomes may help prevent hair loss caused by DHT.
April 2025 in “International Journal of Research in Dermatology” Combining Ayurvedic therapies with minoxidil is more effective for hair growth in men than using minoxidil alone.
April 2025 in “Research Square (Research Square)” Different wool coat types in goats are linked to specific gene expressions, which could improve cashmere quality.
April 2025 in “Brazilian Journal of Hair Health” Early exposure to sexualized content and poor lifestyle choices may lead to early hair loss.
April 2025 in “Drug Design Development and Therapy” Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.
April 2025 in “Archives of Dermatological Research” Topical cetirizine with microneedling effectively promotes hair growth in men with androgenetic alopecia.
April 2025 in “Clinical and Translational Discovery” The ketoconazole gel improved hair growth and is a promising treatment for hair loss.
April 2025 in “Natural Product Communications” The study found that essential oils from Angelica sinensis and Ligusticum sinense ‘Chuanxiong’ effectively promote hair growth in a DHT-induced alopecia model in mice, outperforming 3% minoxidil. The oils increased hair follicle numbers and dermal thickness, and enhanced hair growth-promoting factors in cell models, without causing acute toxicity. These findings suggest that these essential oils could be safe and effective for treating hair loss, with potential applications in aromatherapy and cosmetics. Future clinical evaluations are planned to further assess their efficacy.
April 2025 in “Journal of Ethnopharmacology” April 2025 in “Journal of Ethnopharmacology” The study investigates the active components and mechanisms of Persicae Semen (TR) in treating androgenetic alopecia (AGA) using advanced techniques like UPLC-Q-TOF-MS, network pharmacology, and molecular docking. Amygdalin (Am), identified as the main active compound in TR, was found to promote hair growth by influencing the Wnt/β-catenin and VEGF pathways. Additionally, Am can regulate androgen receptor (AR) and 5α-reductase, which are crucial in AGA development. These findings provide a foundation for the clinical use of TR in AGA treatment, offering a potential alternative to current treatments with significant side effects.